Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 52, 2018 - Issue 3
Journal homepage
129
Views
4
CrossRef citations to date
0
Altmetric
Article

Clinical outcome and time trends of surgically treated renal cell carcinoma between 1986 and 2010: results from a single centre in Sweden

Beata GrabowskaDepartment of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Correspondence[email protected]
,
Emma UlvskogDepartment of Oncology, University Hospital Örebro, Örebro, Sweden;
,
Jessica CarlssonDepartment of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden;
,
Michelangelo FiorentinoDepartment of Pathology, F. Addari Institute of Oncology, S. Orsola Hospital, Bologna, Italy;
,
Francesca GiunchiDepartment of Pathology, F. Addari Institute of Oncology, S. Orsola Hospital, Bologna, Italy;
,
Per LindbladDepartment of Urology, School of Medical Sciences, Örebro University, Örebro, Sweden
&
Pernilla SundqvistDepartment of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden;
show all
Pages 206-212 | Received 17 Aug 2017, Accepted 15 Jan 2018, Published online: 04 Jul 2018

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
  • Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 2008;101:949–958.
  • Lyrdal D, Aldenborg F, Holmberg E, et al. Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979–2001. Scand J Urol. 2013;47:302–310.
  • National Board of Health and Welfare. Cancer incidens in Sweden. 2014. Available from: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/20008/2015-12-26.pdf
  • Thorstenson A, Harmenberg U, Lindblad P, et al. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma. Scand J Urol. 2016;50:2–8.
  • Marley J. Campbell-Walsh urology, 9th Edition (E-dition). Int J Urological Nursing. 2007;1:94–95.
  • Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. JCO. 2007;25:1316–1322.
  • Ljungberg B. Njurcancer nationell kvalitetsregisterrapport 2014. Stockholm. 2015.
  • Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–663.
  • Samaratunga H, Gianduzzo T, Delahunt B. The ISUP system of staging, grading and classification of renal cell neoplasia. J Kidney Cancer Vhl. 2014;1:26–39.
  • Delahunt B, McKenney JK, Lohse CM, et al. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol. 2013;37:311–322.
  • Pichler M, Hutterer GC, Chromecki TF, et al. Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival. Int Urol Nephrol. 2012;44:997–1004.
  • Thorstenson A, Bergman M, Scherman-Plogell AH, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol. 2014;48:231–238.
  • Wahlgren T, Harmenberg U, Sandstrom P, et al. Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008). Br J Cancer. 2013;108:1541–1549.
  • Doeuk N, Guo DY, Haddad R, et al. Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series. BJU Int. 2011;107:1381–1385.
  • Pichler M, Hutterer GC, Chromecki TF, et al. Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010. J Clin Pathol. 2012;65:721–724.
  • Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335:865–875.
  • Moreira DM, Gershman B, Lohse CM, et al. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016;34:1465–1472.
  • Karakiewicz PI, Trinh QD, Lam JS, et al. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol. 2007;52:1428–1436.
  • Sourbier C, Massfelder T. Parathyroid hormone-related protein in human renal cell carcinoma. Cancer Lett. 2006;240:170–182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.